Region: Canada

Shopify joins OIN in further sign of Canadian tech giant's growing patent focus

Despite some familiar griping about IP from its CEO, the e-commerce business is continuing to build its defences

04 May 2021

Japan’s NEC is latest to pick up Blackberry patents ahead of planned portfolio sale

Small-scale transaction follows confirmation that Canadian firm is negotiating with a North American bidder for its 38,000 assets

22 April 2021

Canadian court establishes new approach to fee awards in Allergan v Sandoz

A new starting point for calculating cost awards in complex disputes could help to deter lengthy or unnecessary patent proceedings

05 April 2021

BlackBerry CEO: Majority of cash for patent portfolio expected in upfront payment

After IAM broke news of possible sale last year Canadian tech giant has confirmed it is in exclusive negotiations with a “North American” bidder for a part of its 38,000 asset stockpile

01 April 2021

Panasonic on the attack in latest sign of auto supply chain conflict

Japanese company brings West Texas suit against Canada’s Magna International, a rival seller of ADAS systems for vehicles

01 April 2021

How an army of armchair investors showed why BlackBerry is seeking buyers for its 38,000 patents

The Canadian tech giant has built a licensing operation that brings in more than $300 million annually, but those gains have failed to shift shareholder sentiment

17 February 2021

BlackBerry shares surge on Facebook patent settlement despite absence of detail

Canadian company enjoys a stock price spike after long-running dispute comes to an end, but information about the terms of the agreement is almost non-existent

18 January 2021

Samsung and WiLAN patent transfers point to more semiconductor deal activity

Two separate assignments have seen the Korean tech giant and the NPE acquire assets from IBM and Mediatek

12 January 2021

Huawei bolsters portfolio in deals with Blackberry, Denso

Deals show Chinese company is back in the midst of the secondary market for patents, finding willing partners among major IP owners

12 January 2021

Five key insights into 2020’s drug royalty transactions

It has been a year of creative and flexible deal-making with many life sciences entities taking advantage of the revenues this kind of IP monetisation can deliver

16 December 2020

Unlock unlimited access to all IAM content